ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,364.46
-0.07%
Dow Jones
39,671.04
0.00%
Gold vs US Dollar
2,367.045
-0.62%
Brent Oil
82.305
0.95%
Bitcoin
69,983.27
1.27%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Therapix Biosciences Ltd (TRPX)

  7. Therapix Biosciences Ltd (TRPX) News

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRPX
DateTimeSourceHeadlineSymbolCompany
26/06/202321:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/06/202314:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/06/202314:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
12/06/202312:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/05/202321:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/05/202311:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/05/202322:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRPXTherapix Biosciences Ltd
08/05/202313:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/05/202321:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/04/202314:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/04/202311:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
04/04/202312:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
10/03/202322:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/03/202321:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202314:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202312:47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/02/202311:01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:TRPXTherapix Biosciences Ltd
16/02/202322:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
15/02/202313:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/01/202321:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/01/202321:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
14/12/202221:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
07/12/202218:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
29/11/202217:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/11/202221:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
08/11/202212:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
01/11/202220:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/09/202212:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/09/202216:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/08/202211:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TRPX

Your Recent History

LSE
GCM
Gcm Resources
LSE
POS
Plexus
LSE
NG.
National Grid
LSE
VAST
Vast Resources
LSE
ITV
Itv
LSE
SOLG
Solgold
LSE
AV.
Aviva
LSE
YU.
Yu
LSE
SCE
Surface Transforms
LSE
GGP
Greatland Gold
LSE
AVCT
Avacta
LSE
BP.
Bp
LSE
EZJ
Easyjet
LSE
AGL
Angle
LSE
BT.A
Bt
LSE
NFDS
Northern Foods
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved